We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Nutanix
NTNX
$14.9B
| – | – |
-56,472
| Closed | -$892K |
|
1827
Nutrien
NTR
$32.7B
| – | – |
-789,566
| Closed | -$26.8M |
|
1828
Natera
NTRA
$37.5B
| – | – |
-44,283
| Closed | -$1.32M |
|
1829
Nucor
NUE
$56.4B
| – | – |
-810
| Closed | -$29K |
|
1830
Nu Skin
NUS
$247M
| – | – |
-28,146
| Closed | -$615K |
|
|
NVO
1831
Novo Nordisk
NVO
$216B
| – | – |
-1,626
| Closed | -$49K |
|
1832
Envista
NVST
$4.28B
| – | – |
-59,633
| Closed | -$891K |
|
1833
Northwest Bancshares
NWBI
$2.25B
| – | – |
-100,937
| Closed | -$1.17M |
|
1834
Newell Brands
NWL
$2.16B
| – | – |
-97,271
| Closed | -$1.29M |
|
1835
Nexstar Media Group
NXST
$5.6B
| – | – |
-2,501
| Closed | -$144K |
|
1836
Ocular Therapeutix
OCUL
$1.86B
| – | – |
-32,533
| Closed | -$161K |
|
1837
iShares S&P 100 ETF
OEF
$19.8B
| – | – |
-3,182
| Closed | -$377K |
|
1838
Oneok
OKE
$58.7B
| – | – |
-1,098
| Closed | -$24K |
|
1839
Olin
OLN
$2.64B
| – | – |
-9,611
| Closed | -$112K |
|
1840
Ooma
OOMA
$550M
| – | – |
-44,603
| Closed | -$532K |
|
|
OPI
1841
DELISTED
Office Properties Income Trust
OPI
| – | – |
-156,283
| Closed | -$4.26M |
|
1842
OptimizeRx
OPRX
$117M
| – | – |
-3,698
| Closed | -$34K |
|
1843
OR Royalties Inc
OR
$5.47B
| – | – |
-372,681
| Closed | -$2.76M |
|
1844
OraSure Technologies
OSUR
$273M
| – | – |
-14,217
| Closed | -$153K |
|
1845
Open Text
OTEX
$5.43B
| – | – |
-694
| Closed | -$24K |
|
1846
Ovintiv
OVV
$17.5B
| – | – |
-557,721
| Closed | -$1.51M |
|
1847
Occidental Petroleum
OXY
$57B
| – | – |
-184,086
| Closed | -$2.13M |
|
1848
Pan American Silver
PAAS
$18.6B
| – | – |
-48,818
| Closed | -$700K |
|
1849
Plains GP Holdings
PAGP
$5.23B
| – | – |
-985,018
| Closed | -$5.53M |
|
1850
Paychex
PAYX
$40.4B
| – | – |
-76
| Closed | -$5K |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.